Post-traumatic brain injury: Genetic susceptibility to outcome

Neuroscientist

Volumn 21, Issue 4, 2015, Pages 424-441

  Davidson, Jennilee ^a,b   Cusimano, Michael D ^a   Bendena, William G ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

apolipoprotein E; genes and TBI; head injury; outcome; traumatic brain injury (TBI)

Indexed keywords

ANKYRIN; ANKYRIN REPEAT AND KINASE DOMAIN CONTAINING I; APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM CHANNEL P TYPE; CALCIUM CHANNEL Q TYPE; CATECHOL METHYLTRANSFERASE; DOPAMINE 2 RECEPTOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 6; KIDNEY AND BRAIN EXPRESSED PROTEIN; NEUROFILAMENT HEAVY POLYPEPTIDE; NEUROFILAMENT PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN; PROTEIN P53; PROTEIN PHOSPHATASE 3 CATALYTIC SUBUNIT GAMMA ISOZYME; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

DISABILITY; GENE LOCUS; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; GENETIC TRAIT; GENETIC VARIABILITY; HEAD INJURY; HUMAN; INDUSTRIALIZATION; INJURY SEVERITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETURN TO WORK; REVIEW; TRAUMATIC BRAIN INJURY; ADOLESCENT; ADULT; BRAIN INJURIES; CHILD; CONVALESCENCE; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; METABOLISM; MIDDLE AGED; RISK FACTOR; SIGNAL TRANSDUCTION; YOUNG ADULT;

ADOLESCENT; ADULT; BRAIN INJURIES; CHILD; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; RECOVERY OF FUNCTION; RISK FACTORS; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84937571634     PISSN: 10738584     EISSN: 10894098     Source Type: Journal    
DOI: 10.1177/1073858414543150     Document Type: Review

References (81)

1. Alexander S, Kerr ME, Kim Y, Kamboh MI, Beers SR, Conley YP,. 2007. Apolipoprotein E4 allele presence and functional outcome after severe traumatic brain injury. J Neurotrauma 24 (5): 790-7.
2. Arend WP,. 2002. The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev 3 (4-5): 323-40.
3. Ariza M, Pueyo R, Matarín Mdel M, Junqué C, Mataró M, Clemente I, and others. 2006. Influence of APOE polymorphism on cognitive and behavioural outcome in moderate and severe traumatic brain injury. J Neurol Neurosurg Psychiatry 77 (10): 1191-3.
4. Bagnato S, Minafra L, Bravatà V, Boccagni C, Sant'angelo A, Castiglione A, and others. 2012. Brain-derived neurotrophic factor (Val66Met) polymorphism does not influence recovery from a post-traumatic vegetative state: a blinded retrospective multi-centric study. J Neurotrauma 29 (11): 2050-9.
5. Bales JW, Garringer J, Conley YP, Puccio AM, Okonkwo DO, Dixon CE,. 2011. Association between the PPP3CC gene, coding for the calcineurin gamma catalytic subunit, and severity of traumatic brain injury in humans. J Neurotrauma 28: A-1-134. doi: 10.1089/neu.2011.9945.
6. Blackman JA, Worley G, Strittmatter WJ,. 2005. Apolipoprotein E and brain injury: implications for children. Dev Med Child Neurol 47 (1): 64-70.
7. Brichtová E, Kozák L., 2008. Apolipoprotein E genotype and traumatic brain injury in children-association with neurological outcome. Childs Nerv Syst 24 (3): 349-56.
8. Carter MD, Miller MA, Burkhardt JN, Scanlon JM, Ferrell R, Conley YP, and others. 2011. Variants of SLC6A4 and BDNF in depression risk and onset following severe TBI. J Neurotrauma 28:A-P019. doi: 10.1089/neu.2011.9945.
9. Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control. Report to Congress on mild traumatic brain injury in the United States: steps to prevent a serious publish health problem. 2003. Atlanta, GA: Centers for Disease Control and Prevention.
10. Chamelian L, Reis M, Feinstein A., 2004. Six-month recovery from mild to moderate traumatic brain injury: the role of APOE-ε4 allele. Brain 127 (Pt 12): 2621-8.
11. Chan F, Lanctôt KL, Feinstein A, Herrmann N, Strauss J, Sicard T, and others. 2008. The serotonin transporter polymorphisms and major depression following traumatic brain injury. Brain Inj 22 (6): 471-9.
12. Chiang MF, Chang JG, Hu CJ,. 2003. Association between apolipoprotein E genotype and outcome of traumatic brain injury. Acta Neurochir (Wien) 145 (8): 649-53.
13. Crawford FC, Vanderploeg RD, Freeman MJ, Singh S, Waisman M, Michaels L, and others. 2002. APOE genotype influences acquisition and recall following traumatic brain injury. Neurology 58 (7): 1115-8.
14. Dalla Libera AL, Regner A, de Paolo J, Centenaro L, Martinis TT, Simon D., 2011. IL-6 polymorphism associated with fatal outcome in patients with severe traumatic brain injury. Brain Inj 25 (4): 365-9.
15. Danis VA, Millington M, Hyland VJ, Grennan D., 1995. Cytokine production by normal human monocytes: inter-subject variation and relationship to an IL-1 receptor antagonist (IL-1Ra) gene polymorphism. Clin Exp Immunol 99 (2): 303-10.
16. Dardiotis E, Dardioti M, Hadjigeorgiou GM, Paterakis K., 2006. Re: Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury. Tanriverdi T, and others. Surg Neurol 2006;65:7-10. Surg Neurol 66 (3): 334-5.
17. Dewberry RM, Crossman DC, Francis SE,. 2003. Interleukin-1 receptor antagonist (IL-1RN) genotype modulates the replicative capacity of human endothelial cells. Circ Res 92 (12): 1285-7.
18. Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, and others. 2003. Increased risk of late posttraumatic seizures associated with inheritance of APOE ε4 allele. Arch Neurol 60 (6): 818-22.
19. Dumont P, Leu JI, Della Pietra AC 3rd, George DL, Murphy M., 2003. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33 (3): 357-65.
20. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, and others. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (12): 6917-22.
21. Failla MD, Burkhardt JN, Miller MA, Scanlon JM, Conley YP, Ferrell RE, and others. 2013. Variants of SLC6A4 in depression risk following severe TBI. Brain Inj 27 (6): 696-706.
22. Faul M, Xu L, Wald MM, Coronado VG,. 2010. Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Atlanta. GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control.
23. Friedman G, Froom P, Sazbon L, Grinblatt I, Shochina M, Tsenter J, and others. 1999. Apolipoprotein E-epsilon4 genotype predicts a poor outcome in survivors of traumatic brain injury. Neurology 52 (2): 244-8.
24. Hadjigeorgiou GM, Paterakis K, Dardiotis E, Dardioti M, Aggelakis K, Tasiou A, and others. 2005. IL-1RN and IL-1B gene polymorphisms and cerebral hemorrhagic events after traumatic brain injury. Neurology 65 (7): 1077-82.
25. Hampton T,. 2011. Traumatic brain injury: a growing problem among troops serving in today's wars. JAMA 5: 477-9.
26. Harris N, Brill E, Shohat O, Prokocimer M, Wold D, Arai N, and others. 1986. Molecular basis for heterogeneity of the human p53 protein. Mol Cell Biol 6 (12): 4650-6.
27. Hiekkanen H, Kurki T, Brandstack N, Kairisto V, Tenovuo O., 2009. Association of injury severity, MRI-results and ApoE genotype with 1-year outcome in mainly mild TBI: a preliminary study. Brain Inj 23 (5): 396-402.
28. Horiuchi Y, Ishiguro H, Koga M, Inada T, Iwata N, Ozaki N, and others. 2007. Support for association of the PPP3CC gene with schizophrenia. Mol Psychiatry, 12 (10): 891-3.
29. Isoniemi H, Tenovuo O, Portin R, Himanen L, Kairisto V., 2006. Outcome of traumatic brain injury after three decades-relationship to ApoE genotype. J Neurotrauma 23 (11): 1600-8.
30. Jiang Y, Sun X, Gui L, Xia Y, Tang W, Cao Y, and others. 2007. Correlation between APOE -491AA promoter in ε4 carriers and clinical deterioration in early stage of traumatic brain injury. J Neurotrauma 24 (1): 1802-10.
31. Lendon CL, Harris JM, Pritchard AL, Nicoll JA, Teasdale GM, Murray G., 2003. Genetic variation of the APOE promoter and outcome after head injury. Neurology 61 (5): 683-5.
32. Liberman JN, Stewart WF, Wesnes K, Troncoso J., 2002. Apolipoprotein E ε4 and short-term recovery from predominantly mild brain injury. Neurology 58 (7): 1038-44.
33. Lichtman SW, Seliger G, Tycko B, Marder K., 2000. Apolipoprotein E and functional recovery from brain injury following postacute rehabilitation. Neurology 55 (10): 1536-9.
34. Lipsky RH, Marini AM,. 2007. Brain-derived neurotrophic factor in neuronal survival and behavior-related plasticity. Ann N Y Acad Sci 1122: 130-43.
35. Lipsky RH, Sparling MB, Ryan LM, Xu K, Salazar AM, Goldman D, and others. 2005. Association of COMT Val158Met genotype with executive functioning following traumatic brain injury. J Neuropsychiatry Clin Neurosci 17 (4): 465-71.
36. Lo TY, Jones PA, Chambers IR, Beattie TF, Forsyth R, Mendelow AD, and others. 2009. Modulating effect of apolipoprotein E polymorphisms on secondary brain insult and outcome after childhood brain trauma. Childs Nerv Syst 25 (1): 47-54.
37. Mahley RW, Huang Y., 2012. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76 (5): 871-85.
38. Mahley RW, Weisgraber KH, Huang Y., 2006. Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease. Proc Natl Acad Sci U S A 103 (15): 5644-51.
39. Martínez-Lucas P, Moreno-Cuesta J, García-Olmo DC, Sánchez-Sánchez F, Escribano-Martínez J, del Pozo AC, and others. 2005. Relationship between the Arg72Pro polymorphism of p53 and outcome for patients with traumatic brain injury. Intensive Care Med 31 (9): 1168-73.
40. McAllister TW, Flashman LA, Harker Rhodes C, Tyler AL, Moore JH, Saykin AJ, and others. 2008. Single nucleotide polymorphisms in ANKK1 and the dopamine D2 receptor gene affect cognitive outcome shortly after traumatic brain injury: a replication and extension study. Brain Inj 22 (9): 705-14.
41. McAllister TW, Rhodes AC, Flashman LA, McDonald BC, Belloni D, Saykin AJ,. 2005. Effect of the dopamine D2 receptor T allele on response latency after mild traumatic brain injury. Am J Psychiatry 162 (9): 1749-51.
42. McAllister TW, Tyler AL, Flashman LA, Rhodes CH, McDonald BC, Saykin AJ, and others. 2012. Polymorphisms in the brain-derived neurotrophic factor gene influence memory and processing speed one month after brain injury. J Neurotrauma 29 (6): 1111-8.
43. McDevitt JK, Tierney RT, Mansell JL, Driban JB, Higgins M, Toone N, and others. 2011. Neuronal structural protein polymorphism and concussion in college athletes. Brain Inj 25 (11): 1108-13.
44. Millar K, Nicoll JA, Thornhill S, Murray GD, Teasdale GM,. 2003. Long term neuropsychological outcome after head injury: relation to APOE genotype. J Neurol Neurosurg Psychiatry 74 (8): 1047-52.
45. Miller MA, Conley Y, Scanlon JM, Ren D, Ilyas Kamboh M, Niyokkuru C, and others. 2010. APOE genetic associations with seizure development after severe traumatic brain injury. Brain Inj 24 (12): 1468-77.
46. Minambres E, Cemborain A, Sánchez-Velasco P, Gandarillas M, Díaz-Regañón G, Sánchez-González U, and others. 2003. Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med 31 (3): 933-8.
47. Nathoo N, Chetry R, van Dellen JR, Connolly C, Naidoo R., 2003. Apolipoprotein E polymorphism and outcome after closed traumatic brain injury: influence of ethnic and regional differences. J Neurosurg 98 (2): 302-6.
48. Neville MJ, Johnstone EC, Walton RT,. 2004. Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat 23 (6): 540-5.
49. Noe E, Ferri J, Colomer C, Moliner B, Chirivella J., 2010. APOE genotype and verbal memory recovery during and after emergence from post-traumatic amnesia. Brain Inj 24 (6): 886-92.
50. Olivecrona M, Wildemyr Z, Koskinen LO,. 2010. The apolipoprotein E ε4 allele and outcome in severe traumatic brain injury treated by an intracranial pressure-targeted therapy. J Neurosurg 112 (5): 1113-9.
51. Ost M, Nylén K, Csajbok L, Blennow K, Rosengren L, Nellgard B., 2008. Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury. Acta Anaesthesiol Scand 52 (10): 1364-9.
52. Ottenbacher KJ, Hsu Y, Granger CV, Fiedler RC,. 1996. The reliability of the functional independence measure: a quantitative review. Arch Phys Med Rehabil 77 (12): 1226-32.
53. Pang Y, Fan LW, Zheng B, Cai Z, Rhodes PG,. 2006. Role of interleukin-6 in lipopolysaccharide-induced brain injury and behavioral dysfunction in neonatal rats. Neuroscience 141 (2): 745-55.
54. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E., 1993. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103 (2): 565-75.
55. Pivac N, Kim B, Nedic G, Joo YH, Kozaric-Kovacic D, Hong JP, and others. 2009. Ethnic differences in brain-derived neurotrophic factor Val66Met polymorphism in Croatian and Korean healthy participants. Croat Med J 50 (1): 43-8.
56. Ponsford J, McLaren A, Schönberger M, Burke R, Rudzki D, Olver J, and others. 2011. The association between apolipoprotein e and traumatic brain injury severity and functional outcome in a rehabilitation sample. J Neurotrauma 28 (9): 1683-92.
57. Poo MM,. 2001. Neurotrophins as synaptic modulators. Nat Rev Neurosci 2 (1): 24-32.
58. Pruthi N, Chandramouli BA, Kuttappa TB, Rao SL, Subbakrishna DK, Abrham MP, and others. 2010. Apolipoprotein E polymorphism and outcome after mild to moderate traumatic brain injury: a study of patient population in India. Neurol India 58 (2): 264-9.
59. Quinn TJ, Smith C, Murray L, Stewart J, Nicoll JA, Graham DI,. 2004. There is no evidence of an association in children and teenagers between the apolipoprotein E ε4 allele and post-traumatic brain swelling. Neuropathol Appl Neurobiol 30 (6): 569-75.
60. Ritchie T, Noble EP,. 2003. Association of seven polymorphisms of the D2 dopamine receptor gene with brain receptor-binding characteristics. Neurochem Res 28 (1): 73-82.
61. Robertson CS, Gopinath SP, Valadka AB, Van M, Swank PR, Goodman JC,. 2011. Variants of the endothelial nitric oxide gene and cerebral blood flow after severe traumatic brain injury. J Neurotrauma 28 (5): 727-37.
62. Russell WR, Smith A., 1961. Post-traumatic amnesia in closed head injury. Arch Neurol 5: 4-17.
63. Santtila SK, Savinainen K, Hurme M., 1998. Presence of the IL-1RA allele 2 (IL1RN∗2) is associated with enhanced IL-1β production in vitro. Scand J Immunol 47 (3): 195-8.
64. Sarnaik AA, Conley YP, Okonkwo DO, Barr TL, Fink EL, Szabo C, and others. 2010. Influence of PARP-1 polymorphisms in patients after traumatic brain injury. J Neurotrauma 27 (3): 465-71.
65. Shadli RM, Pieter MS, Yaacob MJ, Rashid FA,. 2011. APOE genotype and neuropsychological outcome in mild-to-moderate traumatic brain injury: a pilot study. Brain Inj 25 (6): 596-603.
66. Singh PP, Singh M, Mastana SS,. 2006. APOE distribution in world populations with new data from India and the UK. Ann Hum Biol 33 (3): 279-308.
67. Sorbi S, Nacmias B, Piacentini S, Repice A, Latorraca S, Forleo P, and others. 1995. ApoE as a prognostic factor for post-traumatic coma. Nat Med 1 (9): 852.
68. Tanriverdi T, Uzan M, Sanus GZ, Baykara O, Is M, Ozkara C, and others. 2006. Lack of association between the IL1A gene (-889) polymorphism and outcome after head injury. Surg Neurol 65 (1): 7-10.
69. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, and others. 1993. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 91 (4): 403-4.
70. Teasdale G, Jennett B., 1974. Assessment of coma and impaired consciousness. A practical scale. Lancet 2 (7872): 81-4.
71. Teasdale GM, Murray GD, Nicoll JA,. 2005. The association between APOE ε4, age and outcome after head injury: a prospective cohort study. Brain 128 (Pt 11): 2556-61.
72. Teasdale GM, Nicoll JA, Murray G, Fiddes M., 1997. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 350 (9084): 1069-71.
73. Thelma BK, Juyal RC, Dodge HH, Pandav R, Chaandra V, Ganguli M., 2001. APOE polymorphism in a rural older population-based sample in India. Hum Biol 73 (1): 135-44.
74. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G., 1999. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19 (2): 1092-100.
75. Thompson J, Thomas N, Singleton A, Piggott M, Lloyd S, Perry EK, and others. 1997. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 7 (6): 479-84.
76. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE,. 1999. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil 4 (6): 606-15.
77. Uzan M, Tanriverdi T, Baykara O, Kafadar A, Sanus GZ, Tureci E, and others. 2005. Association between interleukin-1 βBeta (IL-1β) gene polymorphism and outcome after head injury: an early report. Acta Neurochir 147 (7): 715-20.
78. Virag L, Szabo C., 2002. The therapeutic potential of poly(ADP-ribose) polymerase inhibitors. Pharmacol Rev 54 (3): 375-429.
79. Wagner AK, Hatz LE, Scanlon JM, Niyonkuru C, Miller MA, Ricker JH, and others. 2012. Association of KIBRA rs17070145 polymorphism and episodic memory in individuals with severe TBI. Brain Inj 26 (13-14): 1658-69.
80. Xi Z, Yu L, Shi Y, Zhang J, Zheng Y, He G, and others. 2007. No association between PPP3CC and schizophrenia in the Chinese population. Schizophr Res 90 (1-3), 357-9.
81. Zhou W, Xu D, Peng X, Zhang Q, Jia J, Crutcher KA,. 2008. Meta-analysis of APOE4 allele and outcome after traumatic brain injury. J Neurotrauma, 25 (4), 279-90.